Clinical Trial Update: Metoprolol to Reduce Perioperative Myocardial Injury [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metoprolol to reduce perioperative myocardial injury has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: University of Chicago | Conditions: Heart Diseases | Phase 3 | Status: COMPLETED | Results posted: 2025-02-05